⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CGEN News
Compugen Ltd
DATROWAY ® Plus Rilvegostomig Showed Promising Tumor Responses in Patients with Metastatic Urothelial Cancer in TROPION-PanTumor03 Phase 2 Trial
businesswire.com
CGEN
Compugen to Present Pooled Analysis of COM701 in Three Phase 1 Trials in Patients with Platinum Resistant Ovarian Cancer at ESMO 2025
prnewswire.com
CGEN
Compugen to Present at SITC 2025
prnewswire.com
CGEN
Q3 Virtual Investor Summit: On-Demand Presentations Now Available
accessnewswire.com
JG
CGEN
COE
GCTK
MRAM
PRSO
UXIN
SPCB
MIND
Compugen to Present Research at the Single Cell Genomics 2025 Conference
prnewswire.com
CGEN